An interventional study of Sodium Hypochlorite 2,5% and Chlorhexidine in Efficacy of Hemostatic Agents, Partial Pulpotomy and Postoperative Pain, sponsored by Cukurova University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 15 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Cukurova University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Pain, Postoperative by Cukurova University — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Cukurova University.
Among the 33 studies in Pain, Postoperative by Cukurova University, this one is the 13th largest by planned enrollment, is one of 2 that started in 2025, is one of 20 with no phase, and was the 28th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →4 of the 33 studies in Pain, Postoperative by Cukurova University are open now, in 1 country. Recruiting first, the newest first:
Cukurova University · Sites in Turkey
Ages 18–69 · Women only
Cukurova University · Sites in Turkey
Ages 18–80
Cukurova University
Ages 18+
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 15 Years to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 75 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 60 across the 33 interventional studies. Of the 26 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cukurova University is the lead sponsor of 261 studies on the registry; 48 are open to participants now.
1 of the studies in Pain, Postoperative by Cukurova University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07568106Cukurova UniversityAdductor Canal Block With or Without Biceps Femoris Short Head Block in Total Knee Arthroplasty | 2027-01-15 |
Add it to your calendar (.ics) → With an account.
Among the 33 studies in Pain, Postoperative by Cukurova University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized clinical trial evaluates the efficacy of sodium hypochlorite (NaOCl), chlorhexidine (CHX), and cold saline as hemostatic agents in partial pulpotomy. The study compares postoperative pain (via VAS scores) and pulp survival (via clinical/radiographic evaluation) at 1, 3, 7 days, 6 months, and 12 months
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
2.5% NaOCl applied for 1 min after pulp exposure.
Drug: Sodium Hypochlorite 2,5%
2% CHX applied for 1 min
Drug: Chlorhexidine
Hemostasis achieved with 4°C saline for 1 min.
Drug: Cold Saline
2.5% NaOCl applied for 1 min to exposed pulp for hemostasis, followed by standard pulp capping
2% CHX applied for 1 min to achieve hemostasis, with identical subsequent steps to NaOCl group
Hemostasis via 4°C saline (1 Min), then standardized pulp capping
Postoperative Pain
The patient will be asked to rate the pain on the 1st, 3rd and 7th day according to VAS. (The patient is asked to score their pain in this range, with 0 being the lowest and 10 being the highest.)
Time frame: 1 week
Pulp Survival Rate
The pulp is expected to be vital, without percussion tenderness and without spontaneous pain
Time frame: 12 months
Clinical Success
Maintaining the integrity of the restoration No need for endodontics treatments
Time frame: 12 months
Ran from May 2025 to primary completion in Nov 2025, 6 months.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 6 months is below that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
Completion moved once since we started tracking on Sep 25, 2026: May 2026 → Mar 2027, on Nov 16, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Chlorhexidine